Search

Author/Creator Marasca, C.

1. A New Classification and Clinical Predictivity for Some Naevus Variants. (15th June 2011)

Authors:
Fabbrocini, G.; Mazzella, C.; Pastore, F.; Monfrecola, A.; Annunziata, M. C.; Mauriello, M. C.; D'Arco, V.; Marasca, C.; De Vita, V.
Other Names:
Chen S. Academic Editor.; Ghanem G. Academic Editor.; Sueoka E. Academic Editor.
Journal:
ISRN oncology
Issue:
Volume 2011(2011)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Age and gender influence on HIDRAdisk outcomes in adalimumab‐treated hidradenitis suppurativa patients. (19th September 2019)

Authors:
Fabbrocini, G.; Marasca, C.; Megna, M.; Peris, K.
Other Names:
Amerio P. investigator.; Ardigò M. investigator.; Argenziano G. investigator.; Berti E. investigator.; Bettoli V. investigator.; Bianchi L. investigator.; Bongiorno M. R. investigator.; Cacciapuoti S. investigator.; Calzavara Pinton P. investigator.; Cannavò S. P. investigator.; Costanzo A. inves...
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 33(2019)Supplement 6
Page Start:
25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Comment on 'The effects of isotretinoin therapy on serum homocysteine, folate and vitamin B12 levels in patients with acne': may retinoids be useful to treat hyperhomocysteinemia found in patients affected by hidradenitis suppurativa?. (19th November 2019)

Authors:
Marasca, C.; Donnarumma, M.; Annunziata, M.C.; Fabbrocini, G.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 34:Number 3(2020)
Page Start:
e120
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real‐life setting. (9th March 2021)

Authors:
Ribero, S.; Ramondetta, A.; Fabbrocini, G.; Bettoli, V.; Potenza, C.; Chiricozzi, A.; Licciardello, M.; Marzano, A.V.; Bianchi, L.; Rozzo, G.; Fania, L.; Marasca, C.; Odorici, G.; Mambrin, A.; Moltrasio, C.; Caposiena Caro, R.D.; Skroza, N.; Quaglino, P.; Siliquini, N.; Dapavo, P.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 35:Number 7(2021)
Page Start:
e441
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Long‐term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side‐effects, improving patients' compliance. (1st April 2019)

Authors:
Marasca, C.; Masarà, A.; Annunziata, M.C.; Bettoli, V.; Luciano, M.A.; Fabbrocini, G.
Journal:
British journal of dermatology
Issue:
Volume 180:Number 4(2019)
Page Start:
949
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗